Physician profile
Lawrence L Wang
NPI 1376568980
$23,365.60
in general payments reported to CMS, 2019-2025
39 companies · $3,245 in 2025
The $3,245 reported for 2025 was more than what 85% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,816 · 2020: $2,452 · 2021: $2,515 · 2022: $2,951 · 2023: $5,813 · 2024: $3,575 · 2025: $3,245.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,776 · Consulting Fee: $2,258 · Education: $599.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,775.94 |
| Consulting Fee | $2,257.50 |
| Education | $599.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,972.80 | 2019-2025 | Skyrizi, Rinvoq, Humira |
| E.R. Squibb & Sons, L.L.C. | $3,249.67 | 2022-2025 | Sotyktu |
| Amgen INC. | $1,921.41 | 2019-2025 | Otezla, Otezla |
| Janssen Biotech, INC. | $1,852.20 | 2019-2025 | Tremfya, Stelara, Remicade |
| Lilly USA, LLC | $1,500.88 | 2019-2025 | Taltz, Olumiant, Ebglyss |
| Novartis Pharmaceuticals Corporation | $1,333.92 | 2019-2025 | |
| Mayne Pharma Commercial LLC | $1,083.45 | 2019-2025 | |
| Dermavant Sciences, INC. | $1,023.50 | 2022-2024 | Vtama |
| Leo Pharma INC. | $866.20 | 2019-2025 | Adbry |
| Ucb, INC. | $820.14 | 2019-2025 | Bimzelx, Cimzia |
| Galderma Laboratories, L.P. | $776.77 | 2019-2025 | Aklief, Oracea, Epsolay |
| Pfizer INC. | $748.20 | 2019-2025 | |
| Arcutis Biotherapeutics, INC. | $565.92 | 2023-2025 | Zoryve |
| Genzyme Corporation | $404.11 | 2019-2024 | |
| Sun Pharmaceutical Industries INC. | $397.40 | 2019-2025 | Winlevi |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.